A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients

NCT02616666 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

632

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Dapagliflozin
DRUG: Standard of Care

Sponsor

University of Liverpool

Collaborators

[object Object]
[object Object]